NCT05950503Recruiting
Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the
Source: ClinicalTrials.gov · Last updated 2 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 10 Jul 2023
- Start date
- 10 Jul 2023
- Primary completion date
- 7 Jun 2026
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Colorectal cancer
- NCT number
- NCT05950503
What you commit to
- Study type: Observational
- Planned participants: 100
- From 10 Jul 2023 to the primary completion date, 7 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major contraindications to liver surgery;
Age
- Age \< 18 years;
Other
- Inability to undergo MRI;
- No written informed consent.
Who the study is looking for
- Age \> 18 years;
- Histological diagnosis of colorectal cancer;
- Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
- At least one measurable liver lesion according to RECIST 1.1 criteria;
- Adequate organ and marrow function.
Age in the registry: 18 years to 85 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Policlinico Agostino Gemelli Coordinator of this site? Confirm its status | Roma | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.